Short Reads

Update with respect to COVID-19 – Regulated Markets Disclosure & Reporting

Update COVID-19 – Regulated Markets Disclosure & Reporting

Update with respect to COVID-19 – Regulated Markets Disclosure & Reporting

16.03.2020 NL law

The developments with respect to COVID-19 raise a number of challenges for issuers of securities listed on a regulated market relating to – among other things – disclosure of information and periodic financial reporting.

The European Securities and Markets Authority (“ESMA”) has made a number of recommendations with respect to the disclosure of information relating to COVID-19.  Two important ESMA disclosure recommendations are:

Market disclosure 

Issuers should disclose as soon as possible any relevant significant information concerning the impacts of COVID-19 on their fundamentals, prospects or financial situation in accordance with their transparency obligations under the Market Abuse Regulation.

Financial Reporting

Issuers should provide transparency on the actual and potential impacts of COVID-19, to the extent possible based on both a qualitative and quantitative assessment on their business activities, financial situation and economic performance in their 2019 year-end financial report if these have not yet been finalised or otherwise in their interim financial reporting disclosures.

In addition to the recommendations from ESMA, we feel that it would be prudent for issuers to take into account the following with respect to the COVID-19 situation:

  • Issuers should regularly evaluate their message and communication plan for updating investors, analysts and other stakeholders to ensure up-to-date and consistent disclosure of information.
  • Issuers should assess whether it is necessary to provide information regarding the expected impact on their medium to long-term financial results, including their results for the remainder of the year.
  • Issuers should be prepared to address questions relating to COVID-19 and its expected impact on their results during investor and analyst meetings and earnings calls. As always, issuers should be mindful not to disclose material non-public information with attendees of such meetings and calls that have not been disclosed properly through a press release.
  • Finally, issuers that have provided guidance to the market regarding their operational or financial results, should consider whether there is a need to update or withdraw such guidance with a view to adequately manage the market’s expectations.

We will continue to closely monitor the legal developments and regulatory recommendations with respect to the COVID-19 situation and provide updates where appropriate.

Team

Related news

20.05.2020 NL law
Perpetual securities not considered equity for Dutch corporate income tax purposes

Short Reads - In a decision of Friday 15 May 2020, the Dutch Supreme Court confirmed that fixed-to-floating rate perpetual equity securities (“perpetual securities”) should not be considered a “participation loan” (deelnemerschapslening) for Dutch tax purposes. Under Dutch tax law, characterization of a debt instrument as a “participation loan” implies that such instrument is deemed equity for Dutch corporate income tax purposes. Characterization of the perpetual securities as a participation loan would have meant that the interest would have been regarded non-deductible dividend.

Read more

14.05.2020 NL law
Wijziging NOW: voorafgaande instemming over openbaarmaking in NOW op gespannen voet met de Awb en de Wob

Short Reads - Op 2 april 2020 is de Tijdelijke noodmaatregel overbrugging voor behoud van werkgelegenheid (“NOW”) in werking getreden. De regeling is snel tot stand gekomen als maatregel tegen de nadelige gevolgen van de corona-crisis. In de praktijk bleek dat de regeling onvolkomenheden bevat en wijzigingen en aanvullingen nodig zijn. Op 4 mei 2020 is een regeling tot wijziging van de NOW gepubliceerd in de Staatscourant.

Read more

20.05.2020 NL law
Stibbe in Amsterdam answers questions from consumers, small business foundations and NGOs about the coronavirus [updated]

Inside Stibbe - In a special Q&A (in Dutch), lawyers from our Amsterdam office share their legal expertise and strive to provide answers to questions put to us by consumers, self-employed persons, enterprises large and small, foundations and NGOs as a result of the corona crisis.

Read more

14.05.2020 NL law
Corona-special

Articles - Sinds de uitbraak van het coronavirus als veroorzaker van de ziekte COVID-19 lijkt alles anders. Tijdens zijn persconferentie op 31 maart jongstleden verwoordde minister-president Rutte dat door de huidige crisis, als gevolg van de uitbraak van het coronavirus, te omschrijven als een van de hevigste crises in de geschiedenis buiten oorlogstijd. Als historicus had de minister-president wellicht kunnen wijzen op de pandemie die letterlijk een eeuw geleden de wereld trof, toen het virus dat bekend staat als de ‘Spaanse griep’ in de nasleep van een oorlog rondwaarde.

Read more

13.05.2020 NL law
De algemene vergadering en COVID-19

Articles - De uitbraak van het coronavirus stelt ons land voor enorme uitdagingen en heeft aanleiding gegeven tot overheidsmaatregelen die het dagelijks leven van alle Nederlanders verregaand beïnvloeden. Menig huiskamer is omgetoverd tot home-office, horecagelegenheden zijn gesloten en de vele zomerfestivals die ons land kent, kunnen voorlopig geen doorgang vinden. Maar de coronacrisis heeft ook gevolgen voor de organisatie van het belangrijkste evenement voor aandeelhouders van Nederlandse beursvennootschappen: de jaarlijkse algemene vergadering (AVA).

Read more

This website uses cookies. Some of these cookies are essential for the technical functioning of our website and you cannot disable these cookies if you want to read our website. We also use functional cookies to ensure the website functions properly and analytical cookies to personalise content and to analyse our traffic. You can either accept or refuse these functional and analytical cookies.

Privacy – en cookieverklaring